Diagnosing Cognitive Impairment After COVID-19 Infection
Eye-tracking as a non-invasive tool capable of identifying COVID-19 patients at risk for neurological impairments
- US Provisional Application just filed in May on novel eye‑tracking algorithms and methods for diagnosing neurological and psychiatric diseases.
- Provisional patent
- Development partner
- University spin out
- Seeking investment